Daewoong Bio says it will invest 65.0 billion won to build a cGMP plant producing a variety of pharmaceutical raw materials.
“To expand our production capacity of export-oriented pharmaceutical bulks, including UDCA and antibiotiotics, we will build a new plant,’’ a company official said.
The ground-breaking ceremony was held at Hwansung, Kyunggi Province on March 8.
The plant will be ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.